收费全文 | 160篇 |
免费 | 20篇 |
国内免费 | 1篇 |
电工技术 | 2篇 |
化学工业 | 61篇 |
金属工艺 | 3篇 |
建筑科学 | 1篇 |
能源动力 | 4篇 |
轻工业 | 20篇 |
水利工程 | 4篇 |
无线电 | 14篇 |
一般工业技术 | 49篇 |
冶金工业 | 6篇 |
原子能技术 | 2篇 |
自动化技术 | 15篇 |
2024年 | 3篇 |
2023年 | 4篇 |
2022年 | 17篇 |
2021年 | 25篇 |
2020年 | 14篇 |
2019年 | 8篇 |
2018年 | 19篇 |
2017年 | 7篇 |
2016年 | 15篇 |
2015年 | 10篇 |
2014年 | 15篇 |
2013年 | 15篇 |
2012年 | 6篇 |
2011年 | 7篇 |
2010年 | 4篇 |
2009年 | 3篇 |
2008年 | 2篇 |
2007年 | 2篇 |
2006年 | 3篇 |
2003年 | 1篇 |
2002年 | 1篇 |
Significance: The polymeric PTX nanoparticles free from the cremophor EL will help in eliminating the shortcomings of the existing delivery system as cremophor EL causes serious allergic reactions to the subjects after intravenous use.
Methods and results: Paclitaxel-loaded nanoparticles were formulated by nanoprecipitation method. The diminutive nanoparticles (143.2?nm) with uniform size throughout (polydispersity index, 0.115) and high entrapment efficiency (95.34%) were obtained by employing the Box–Behnken design for the optimization of the formulation with the aid of desirability approach-based numerical optimization technique. Optimized levels for each factor viz. polymer concentration (X1), amount of organic solvent (X2), and surfactant concentration (X3) were 0.23%, 5?ml %, and 1.13%, respectively. The results of the hemocompatibility studies confirmed the safety of PLGA-based nanoparticles for intravenous administration. Pharmacokinetic evaluations confirmed the longer retention of PTX in systemic circulation.
Conclusion: In a nutshell, the developed polymeric nanoparticle formulation of PTX precludes the inadequacy of existing PTX formulation and can be considered as superior alternative carrier system of the same. 相似文献